JPS5512001B2 - Improving the compatibility of gamma globulins - Google Patents

Improving the compatibility of gamma globulins

Info

Publication number
JPS5512001B2
JPS5512001B2 JP15974275A JP15974275A JPS5512001B2 JP S5512001 B2 JPS5512001 B2 JP S5512001B2 JP 15974275 A JP15974275 A JP 15974275A JP 15974275 A JP15974275 A JP 15974275A JP S5512001 B2 JPS5512001 B2 JP S5512001B2
Authority
JP
Japan
Prior art keywords
compatibility
improving
gamma globulins
globulins
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP15974275A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5191321A (en
Inventor
Waldemar Schneider
Dietrich Wolter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JPS5191321A publication Critical patent/JPS5191321A/ja
Publication of JPS5512001B2 publication Critical patent/JPS5512001B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP15974275A 1975-01-02 1975-12-27 Improving the compatibility of gamma globulins Expired JPS5512001B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (2)

Publication Number Publication Date
JPS5191321A JPS5191321A (en) 1976-08-10
JPS5512001B2 true JPS5512001B2 (en) 1980-03-29

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15974275A Expired JPS5512001B2 (en) 1975-01-02 1975-12-27 Improving the compatibility of gamma globulins

Country Status (20)

Country Link
JP (1) JPS5512001B2 (cg-RX-API-DMAC7.html)
AT (1) AT344883B (cg-RX-API-DMAC7.html)
AU (1) AU505416B2 (cg-RX-API-DMAC7.html)
BE (1) BE837211A (cg-RX-API-DMAC7.html)
CA (1) CA1058075A (cg-RX-API-DMAC7.html)
DD (1) DD121875A5 (cg-RX-API-DMAC7.html)
DE (1) DE2500076C3 (cg-RX-API-DMAC7.html)
DK (1) DK144679C (cg-RX-API-DMAC7.html)
EG (1) EG11987A (cg-RX-API-DMAC7.html)
ES (1) ES443982A1 (cg-RX-API-DMAC7.html)
FR (1) FR2296429A1 (cg-RX-API-DMAC7.html)
GB (1) GB1495159A (cg-RX-API-DMAC7.html)
IE (1) IE43449B1 (cg-RX-API-DMAC7.html)
IL (1) IL48766A (cg-RX-API-DMAC7.html)
IN (1) IN143525B (cg-RX-API-DMAC7.html)
NL (1) NL179824C (cg-RX-API-DMAC7.html)
PL (1) PL99599B1 (cg-RX-API-DMAC7.html)
SE (1) SE437470B (cg-RX-API-DMAC7.html)
SU (1) SU576898A3 (cg-RX-API-DMAC7.html)
ZA (1) ZA758050B (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
EP1954718B1 (en) 2005-11-30 2014-09-03 AbbVie Inc. Anti-a globulomer antibodies, antigen-binding moieties thereof, corresponding hybridomas, nucleic acids, vectors, host cells, methods of producing said antibodies, compositions comprising said antibodies, uses of said antibodies and methods of using said antibodies
RU2432362C2 (ru) 2005-11-30 2011-10-27 Эбботт Лэборетриз Моноклональные антитела и их применения
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (en) 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Method for the treatment of amyloidoses
WO2011130377A2 (en) 2010-04-15 2011-10-20 Abbott Laboratories Amyloid-beta binding proteins
EP3533803B1 (en) 2010-08-14 2021-10-27 AbbVie Inc. Anti-amyloid-beta antibodies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (cg-RX-API-DMAC7.html) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (cg-RX-API-DMAC7.html) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
SE437470B (sv) 1985-03-04
IL48766A (en) 1979-11-30
BE837211A (fr) 1976-06-30
ATA981675A (de) 1977-12-15
DE2500076A1 (de) 1976-07-08
IL48766A0 (en) 1976-02-29
DK584375A (da) 1976-07-03
FR2296429A1 (fr) 1976-07-30
SU576898A3 (ru) 1977-10-15
AU505416B2 (en) 1979-11-22
IE43449B1 (en) 1981-02-25
GB1495159A (en) 1977-12-14
IE43449L (en) 1976-07-02
EG11987A (en) 1981-12-31
JPS5191321A (en) 1976-08-10
NL179824C (nl) 1986-11-17
DE2500076C3 (de) 1982-11-18
DE2500076B2 (de) 1979-02-22
AU8792175A (en) 1977-07-14
ES443982A1 (es) 1977-07-16
DD121875A5 (cg-RX-API-DMAC7.html) 1976-09-05
IN143525B (cg-RX-API-DMAC7.html) 1977-12-17
SE7514388L (sv) 1976-07-05
NL7514627A (nl) 1976-07-06
ZA758050B (en) 1976-12-29
FR2296429B1 (cg-RX-API-DMAC7.html) 1978-12-01
PL99599B1 (pl) 1978-07-31
NL179824B (nl) 1986-06-16
CA1058075A (en) 1979-07-10
DK144679B (da) 1982-05-10
DK144679C (da) 1982-10-11
AT344883B (de) 1978-08-10

Similar Documents

Publication Publication Date Title
CS254576A2 (en) Pristroj pro automaticke svarovani trubek
JPS51133669A (en) Damper
PH12858A (en) Closure
JPS5512001B2 (en) Improving the compatibility of gamma globulins
CS120476A2 (en) Zpusob regulace vypalovaciho procesu u vypalovaciho zarizeni pro vyrobu cementarskeho slinku
JPS5197009A (en) **he***** **
JPS5198252A (en) **he*** *********no
GB1519237A (en) Cephalosporins
JPS5191229A (en) * * ****no***so*******so*********************o*tsuuno***no
AU2008776A (en) Cephalosporins
NZ182403A (en) Cephalosporins
GB1554918A (en) Cephalosporins
KE3154A (en) Cephalosporins
AU1303576A (en) Cephalosporins
IL50546A0 (en) New cephalosporins
JPS5278717A (en) Component parts
AU8114275A (en) Closure
JPS5195616A (en) Kanno setsuzokuhoho
JPS5180107A (en) Hansokikito chijogawatono kanno johodensohoshiki
HK478A (en) The preparation of n-alkenyl-2-aminomethyl-pyrrolidines
AU1244276A (en) Cephalosporins
CS193542B2 (en) Sttachment of the container
JPS5184083A (en) of keeburunotanmatsumitsupusochi
JPS5278718A (en) Component parts
ZA766972B (en) Cephalosporins